Moreover, ATO, a Gli inhibitor, was identified to reduce viability and clonal growth and induce apoptosis of both embryonal and alveolar rhabdomyosarcoma cell lines (Boehme et al. 2016). This evidence concerns the gene GLI1 and rhabdomyosarcoma.